Dance in Parkinson's Disease. A Greek Pilot Study
Effects of a Structured Dance Program in Parkinson's Disease. A Greek Pilot Study
1 other identifier
interventional
16
1 country
1
Brief Summary
Dance for Parkinson's Disease® (DfPD®) is a structured dance program that has never been evaluated in Greek PD population. This study assesses for the first time the efficacy, safety and feasibility of DfPD® program in Greek PD patients. A total of 16 early-to-mid-stage PD patients underwent a total of 16 60-min classes of adjusted to Greek music and dance culture DfPD®, twice weekly, over 8 weeks. Assessments were performed at baseline and at the end of the study period and included quality of life, depressive symptoms, fatigue, cognitive functions, balance and body mass index. Safety and feasibility were also assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable parkinson-disease
Started May 2019
Shorter than P25 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 28, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2019
CompletedFirst Submitted
Initial submission to the registry
October 16, 2021
CompletedFirst Posted
Study publicly available on registry
November 26, 2021
CompletedNovember 26, 2021
November 1, 2021
2 months
October 16, 2021
November 14, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change in total score of Parkinson's Disease Questionnaire-8
Minimum score 0, Maximum score 100. A higher score indicates worse quality of life.
Baseline (week 1), end of intervention (week 10)
Occurence of Emergent Adverse Events
Occurrence of adverse events comprising falls, injuries, muscle soreness or excessive fatigue.
During the intervention (week 2-9)
Financial Feasibility Assessment
No cost for the studio and the dance instructor.
During the intervention (week 2-9)
Adherence and Attrition Assessment
Adherence and attrition rates; an adherence rate ≥70% is considered as high in elderly with functional limitations, and attrition rate ≤15% is considered acceptable by the PEDro scale.
During the intervention (week 2-9)
Assessment of Willingness to Continue the Program after the Intervention
Verbal statement for continuing the program after the end of the intervention
End of intervention (week 10)
Assessment of Recruitment Rates
Target, up to 2 months for 16 participants.
Start of Recruitment (-3 months), Baseline (week 1)
Secondary Outcomes (5)
Change in total score of Beck Depression Inventory-II
Baseline (week 1), end of intervention (week 10)
Change in total score of Parkinson Fatigue Scale-16
Baseline (week 1), end of intervention (week 10)
Change in total score of Montreal Cognitive Assessment
Baseline (week 1), end of intervention (week 10)
Change in total score of Berg Balance Scale
Baseline (week 1), end of intervention (week 10)
Change in Body Mass Index
Baseline (week 1), end of intervention (week 10)
Study Arms (1)
Dance for PD® classes
EXPERIMENTALDance for PD® was developed by the Brooklyn Parkinson Group (BPG) in collaboration with the Mark Morris Dance Group (MMDG) in 2001. It was designed to introduce people with PD to techniques used by dancers to control movement and it integrates different dance genres while participants dance individually and in groups rather than partnered.
Interventions
The intervention consisted of 16 60-min classes, performed twice weekly over a period of 8 weeks and instructed by a single researcher who had the approval to use it for research reasons.
Eligibility Criteria
You may qualify if:
- Age ≥18 years
- An established diagnosis of idiopathic PD of an early-to-moderate severity; that is from 0 to 2,5 according to Hoehn and Yahr (H\&Y) stages
- Ability to understand, write and speak in Greek
- Written consent for participating into the study
You may not qualify if:
- A diagnosis of a non-PD tremor disorder
- Moderate-to-severe PD (≥3 H\&Y stages) due to a high falls risk
- Serious health or disability issues (either physical or mental) due of which exercise is not permitted and/or basic instructions during the program cannot be followed
- Mental disorder not related to PD
- Any disease other than PD which could affect mobility levels
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Laboratory of Neuromuscular and Cardiovascular Study of Motion (LANECASM)
Athens, Attica, 12243, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michail Elpidoforou, MSc
Laboratory of Neuromuscular and Cardiovascular Study of Motion (LANECASM)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 16, 2021
First Posted
November 26, 2021
Study Start
May 28, 2019
Primary Completion
July 30, 2019
Study Completion
July 31, 2019
Last Updated
November 26, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share